Company Monitoring Page for biotech

latest headlines for company on cafepharma

Biotech Calendar: Key Dates for October
TheStreet.com
Mon, 10/3/11 - 11:13 am
Tags:
biotech, flurosorafenib, ONYX Pharmaceuticals, Bayer, Rigel, Teva Pharmaceuticals, Biogen Idec, BG-12, Heplisav, Amgen, Dynavax, Pacira, Bristol-Myers Squibb, Dapagliflozin, EXPAREL, cabozantinib, Exelixis
Why Universities Are Key to the Future of Biotech
Xconomy
Mon, 10/3/11 - 11:04 am
Tags:
biotech
Early Stage Biotech Financing: Fewer, Leaner, and Better?
Forbes
Mon, 10/3/11 - 10:42 am
Tags:
biotech, financing
Biotech Investors Bow Out as Hurdles Grow
Bloomberg
Thu, 09/29/11 - 09:06 am
Tags:
investors, Human Genome Sciences, Savient, biotech, Dendreon, Vertex, Acorda
Tougher FDA Approval Process Weighs on Biotech Sector
Yahoo/MarketWire
Wed, 09/21/11 - 10:15 pm
Tags:
FDA, biotech
Billion Dollar Policy Ideas for Supporting Biotech Innovation
Forbes
Thu, 09/15/11 - 09:41 am
Tags:
innovation, biotech
UK's biotech stars may be fading, but new hopefuls shine
Fierce Biotech
Tue, 08/30/11 - 12:17 pm
Tags:
UK, biotech
Big Pharma Eyes Speculative Biotech Firms
Yahoo/MarketWire
Thu, 08/18/11 - 09:46 pm
Tags:
Big Pharma, biotech
Is China preparing to challenge the U.S. for biotech supremacy?
Fierce Biotech
Wed, 08/17/11 - 08:57 am
Tags:
China, biotech
China: The next biotech superpower?
CNN/Fortune
Mon, 08/15/11 - 06:28 pm
Tags:
China, biotech
Analysts see an upside after market swings bludgeon biotechs
Fierce Biotech
Mon, 08/15/11 - 12:00 pm
Tags:
biotech, analysts
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
Tags:
biotech, drug approvals, FDA, Eyelea, Regeneron, Dendreon, Provenge, NuPathe, Zelrix, Adcetris, Seattle Genetics, Soliris, Alexion, Dapagliflozin, AstraZeneca, Bristol-Myers Squibb, EXPAREL, Pacira, Roche, Zelboraf, Iluvien, Alimera, Bio-T-Gel, Teva Pharmaceuticals, BioSante, Zevalin, Spectrum, ruxolitinib, Incyte, Novartis, Pfizer, crizotinib, Antares, Anturol, Bydureon, Amlyin, Eli Lilly, Alkermes, AZ-004, Alexza, Corlux, Corcept Therapeutics, Affymax, Takeda, peginesatide, Levadex, MAP Pharmaceuticals
Venture Investing In Biotech Continues To Drop
Pharmalot
Thu, 08/11/11 - 11:13 am
Tags:
biotech, venture capital
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus
Motley Fool
Mon, 08/8/11 - 09:18 am
Tags:
Dendreon, biotech, Provenge, prostate cancer
Biotech Revenues Rise, But So Do R&D Cutbacks
Pharmalot
Fri, 07/29/11 - 10:11 am
Tags:
biotech, earnings, R&D
Biotechnology Bounces Back With 46% Rise in Venture Capital
Bloomberg
Wed, 07/20/11 - 11:22 am
Tags:
venture capital, biotech
Do pharma BOD rosters clash with biotech strategy?
Fierce Biotech
Tue, 07/19/11 - 12:20 pm
Tags:
biotech, R&D
The 15 Most-Watched Biotech Stocks
Motley Fool
Mon, 07/11/11 - 06:52 pm
Tags:
biotech, Gilead Sciences, Dendreon, PDL Biopharma, Cell Therapeutics, Amgen, Aeterna Zentaris, Xoma, Geron, Orexigen, Zalicus, Spectrum Pharmaceuticals, Ariad Pharmaceuticals, Biogen Idec, Momenta, StemCells
Should Biotech Investors Go Where Institutions Won't?
Investopedia
Thu, 07/7/11 - 12:04 pm
Tags:
investors, biotech, Aeterna Zentaris, YM BioSciences, Ziopharm, Oncothyreon, Seattle Genetics, Exelixis, MannKind, MELA Sciences, Neoprobe, Zalicus
Biotechs are looking at a new normal
Boston Globe, MA
Wed, 06/29/11 - 10:27 am
Tags:
biotech

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.